Saturday 17 October 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
291.67
5.52
−1.86%
Follow UFPT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
18.31% | 17.82% | 17.17% | 17.05% | |
Piotroski F-Score |
6 | 5 | 5 | 4 | |
| 10.40% | 10.64% | 10.42% | 10.98% | ||
ROIC |
10.65% | 10.44% | 10.15% | 10.29% | |
Return on Tangible Assets |
34.73% | 33.28% | 30.43% | 30.96% | |
Average Days of Receivables |
53.10 | 53.42 | 61.48 | 67.82 | |
Free Cash Flow per Share |
11.34 | 10.26 | 9.01 | 7.95 | |
Free Cash Flow |
87.47 | 79.03 | 69.55 | 61.50 | |
Capital Expenditures |
(12.02) | (12.87) | (11.75) | (10.08) | |
| Other line items | |||||
Cash ROIC |
15.01% | 13.31% | 11.40% | 10.20% | |
Accounts Receivable Turnover |
6.70 | 6.78 | 6.10 | 6.19 | |
Accounts Payable Turnover |
15.35 | 17.81 | 15.01 | 16.24 | |
Inventory Turnover |
4.89 | 4.96 | 4.75 | 4.88 | |
Average Days of Payables |
25.14 | 20.50 | 23.79 | 26.64 | |
Days of Inventory on Hand |
73.56 | 73.32 | 78.64 | 80.89 | |
Tax Rate |
(0.18) | (0.17) | (0.18) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.56% | 12.85% | 13.10% | 13.27% | |
Share Based Compensation of Revenue |
1.42% | 1.47% | 1.54% | 1.63% | |
Interest Coverage |
8.27 | 9.42 | 10.60 | 12.40 | |
Operating CF/Net income |
1.48 | 1.35 | 1.18 | 0.99 | |
Depreciation/Fixed assets |
0.24 | 0.24 | 0.25 | 0.26 | |
Capex/Depreciation |
(0.64) | (0.67) | (0.60) | (0.51) | |
Revenue per Share |
77.54 | 78.23 | 78.86 | 81.61 | |
Operating CF per Share |
12.90 | 11.93 | 10.53 | 9.25 | |
Capex per Share |
(1.56) | (1.67) | (1.52) | (1.30) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates